
Paul M. Rivard
Examiner (ID: 3272)
| Most Active Art Unit | 1304 |
| Art Unit(s) | 2899, 1304, 1734 |
| Total Applications | 355 |
| Issued Applications | 271 |
| Pending Applications | 27 |
| Abandoned Applications | 57 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20134812
[patent_doc_number] => 20250241856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-31
[patent_title] => PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/179554
[patent_app_country] => US
[patent_app_date] => 2025-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19179554
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/179554 | PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND USES THEREOF | Apr 14, 2025 | Pending |
Array
(
[id] => 20083546
[patent_doc_number] => 20250213482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => OXYGEN-ENHANCED ADAPTIVE FUNCTIONAL BEVERAGE FOR ANTI-AGING AND METHOD OF PREPARATION
[patent_app_type] => utility
[patent_app_number] => 19/086165
[patent_app_country] => US
[patent_app_date] => 2025-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19086165
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/086165 | OXYGEN-ENHANCED ADAPTIVE FUNCTIONAL BEVERAGE FOR ANTI-AGING AND METHOD OF PREPARATION | Mar 20, 2025 | Pending |
Array
(
[id] => 20178186
[patent_doc_number] => 20250262144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => Deodorant
[patent_app_type] => utility
[patent_app_number] => 19/055601
[patent_app_country] => US
[patent_app_date] => 2025-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19055601
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/055601 | Deodorant | Feb 17, 2025 | Pending |
Array
(
[id] => 20437451
[patent_doc_number] => 12508272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Long-acting liposomal composition for treatment of pain in articular disorders
[patent_app_type] => utility
[patent_app_number] => 18/986700
[patent_app_country] => US
[patent_app_date] => 2024-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 13851
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18986700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/986700 | Long-acting liposomal composition for treatment of pain in articular disorders | Dec 18, 2024 | Issued |
Array
(
[id] => 19982692
[patent_doc_number] => 20250120914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/912716
[patent_app_country] => US
[patent_app_date] => 2024-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18912716
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/912716 | Lipid nanoparticles | Oct 10, 2024 | Issued |
Array
(
[id] => 19975973
[patent_doc_number] => 12343429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Method of delivery of DNA or RNA cargo unshielded lipid nanoparticles and compositions thereof
[patent_app_type] => utility
[patent_app_number] => 18/906740
[patent_app_country] => US
[patent_app_date] => 2024-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 80
[patent_no_of_words] => 26634
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18906740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/906740 | Method of delivery of DNA or RNA cargo unshielded lipid nanoparticles and compositions thereof | Oct 3, 2024 | Issued |
Array
(
[id] => 19975973
[patent_doc_number] => 12343429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Method of delivery of DNA or RNA cargo unshielded lipid nanoparticles and compositions thereof
[patent_app_type] => utility
[patent_app_number] => 18/906740
[patent_app_country] => US
[patent_app_date] => 2024-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 80
[patent_no_of_words] => 26634
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18906740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/906740 | Method of delivery of DNA or RNA cargo unshielded lipid nanoparticles and compositions thereof | Oct 3, 2024 | Issued |
Array
(
[id] => 20185849
[patent_doc_number] => 12396949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom
[patent_app_type] => utility
[patent_app_number] => 18/806627
[patent_app_country] => US
[patent_app_date] => 2024-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 5301
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18806627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/806627 | Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom | Aug 14, 2024 | Issued |
Array
(
[id] => 19903100
[patent_doc_number] => 12280084
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-22
[patent_title] => Fenugreek formulation for lowering blood glucose and weight loss
[patent_app_type] => utility
[patent_app_number] => 18/765624
[patent_app_country] => US
[patent_app_date] => 2024-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765624
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765624 | Fenugreek formulation for lowering blood glucose and weight loss | Jul 7, 2024 | Issued |
Array
(
[id] => 19343563
[patent_doc_number] => 20240252526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => TREATMENT OF HEMATOLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/632083
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18632083
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/632083 | TREATMENT OF HEMATOLOGICAL DISORDERS | Apr 9, 2024 | Pending |
Array
(
[id] => 20142852
[patent_doc_number] => 12377167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma
[patent_app_type] => utility
[patent_app_number] => 18/619103
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 12368
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18619103
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/619103 | Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma | Mar 26, 2024 | Issued |
Array
(
[id] => 20142852
[patent_doc_number] => 12377167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma
[patent_app_type] => utility
[patent_app_number] => 18/619103
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 12368
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18619103
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/619103 | Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma | Mar 26, 2024 | Issued |
Array
(
[id] => 19593101
[patent_doc_number] => 12150919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Nano liquid composition containing curcumin have the ability to treating burns and increasing the effect of scar healing and method of manufacturing the same
[patent_app_type] => utility
[patent_app_number] => 18/611735
[patent_app_country] => US
[patent_app_date] => 2024-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 86
[patent_no_of_words] => 14022
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18611735
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/611735 | Nano liquid composition containing curcumin have the ability to treating burns and increasing the effect of scar healing and method of manufacturing the same | Mar 20, 2024 | Issued |
Array
(
[id] => 19768560
[patent_doc_number] => 20250049986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => KITS FOR PREPARING A REACTIVE GRAFT MATERIAL AND INJECTING THE GRAFT MATERIAL INTO A PATIENT
[patent_app_type] => utility
[patent_app_number] => 18/612062
[patent_app_country] => US
[patent_app_date] => 2024-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612062
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/612062 | KITS FOR PREPARING A REACTIVE GRAFT MATERIAL AND INJECTING THE GRAFT MATERIAL INTO A PATIENT | Mar 20, 2024 | Pending |
Array
(
[id] => 19830788
[patent_doc_number] => 20250082574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 18/608350
[patent_app_country] => US
[patent_app_date] => 2024-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608350
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/608350 | INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES | Mar 17, 2024 | Pending |
Array
(
[id] => 19830788
[patent_doc_number] => 20250082574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 18/608350
[patent_app_country] => US
[patent_app_date] => 2024-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608350
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/608350 | INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES | Mar 17, 2024 | Pending |
Array
(
[id] => 19556277
[patent_doc_number] => 20240368069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => OPHTHALMIC FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/608522
[patent_app_country] => US
[patent_app_date] => 2024-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/608522 | OPHTHALMIC FORMULATION | Mar 17, 2024 | Abandoned |
Array
(
[id] => 20465293
[patent_doc_number] => 12521322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Foaming oral care compositions
[patent_app_type] => utility
[patent_app_number] => 18/589567
[patent_app_country] => US
[patent_app_date] => 2024-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13955
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18589567
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/589567 | Foaming Oral Care Compositions | Feb 27, 2024 | Issued |
Array
(
[id] => 19373876
[patent_doc_number] => 12065425
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-20
[patent_title] => 9-(2-hydroxyquinoline-3-YL)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/435999
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4089
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/435999 | 9-(2-hydroxyquinoline-3-YL)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound | Feb 6, 2024 | Issued |
Array
(
[id] => 19241972
[patent_doc_number] => 12012391
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-06-18
[patent_title] => 9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/436000
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4100
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/436000 | 9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound | Feb 6, 2024 | Issued |